What are the current prevalence and incidence rates of ischemic heart disease (IHD) globally?
Best insight from top research papers
The current global prevalence of ischemic heart disease (IHD) is estimated to affect around 126 million individuals, approximately 1.72% of the world's population, with an expected increase to over 1,845 per 100,000 population by 2030 . In 2017, there were 10.6 million new cases of IHD, resulting in 8.9 million deaths globally . The burden of IHD remains high, particularly in regions with lower socio-demographic index (SDI), with high systolic blood pressure identified as a significant contributor to disability-adjusted life years (DALYs) globally . Despite the increase in the crude number of IHD cases, the global age-standardized incidence rate of IHD has actually decreased by 27% from 1990 to 2017 .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| Ischemic heart disease (IHD) rates vary globally, with higher prevalence in South Asia, the Middle East, and Africa compared to Western populations, influenced by diverse risk factors. | |
| Global prevalence of IHD in 2017 was 126.5 million, with 10.6 million new cases. Despite decreasing age-standardized rates, burden metrics increased globally from 1990-2017. | |
| The prevalence and incidence rates of ischemic heart disease (IHD) globally have increased from 1990 to 2017, with a 75% increase in prevalence and a 52% increase in incidence. | |
| In 2017, globally, there were 10.6 million cases and 8.9 million deaths due to ischemic heart disease, with declining age-standardized rates from 1990 to 2017. | |
377 Citations | Global prevalence of ischemic heart disease (IHD) is 1,655 per 100,000 population, with around 126 million affected individuals. Incidence increases with age, affecting men more than women. |
Related Questions
What is the current global prevalence of thrombolysis as a treatment for ST-elevation myocardial infarction (STEMI)?5 answersThe current global prevalence of thrombolysis as a treatment for ST-elevation myocardial infarction (STEMI) varies across different regions. In Poland, where primary percutaneous coronary intervention (PPCI) is the preferred treatment, thrombolysis is selectively used at a stable level during primary PCI in highly thrombotic STEMI lesions. On the other hand, in resource-limited settings like Bolan Medical Complex Hospital in Quetta, effective thrombolysis was more prevalent than failed thrombolysis, highlighting the utility of thrombolysis in such environments. Despite the advancements in care, including the standard use of primary PCI, some non-PCI-capable hospitals still rely on thrombolysis, especially during the COVID-19 pandemic, when access to interventional cardiology services may be limited. These variations underscore the importance of individualized approaches to STEMI treatment based on available resources and regional guidelines.
What is the current global prevalence of dyslipidemia?5 answersThe current global prevalence of dyslipidemia is a significant public health concern, with variations observed across different regions. Dyslipidemia, characterized by abnormal lipid levels, is a major risk factor for cardiovascular diseases. Studies indicate a rising trend in dyslipidemia over the past few decades, emphasizing the importance of addressing this issue on a global scale. For instance, hypercholesterolemia, a common form of dyslipidemia, remains prevalent and is associated with increased cardiovascular risk. The burden of dyslipidemia is substantial, with a considerable proportion of individuals unaware of their elevated lipid levels. These findings underscore the necessity of implementing strategies to raise awareness, promote healthy lifestyles, and enhance lipid management to mitigate the impact of dyslipidemia on cardiovascular health worldwide.
What is the global prevalence of CVD?4 answersThe global prevalence of cardiovascular disease (CVD) is significant, affecting a substantial proportion of the population worldwide. Studies indicate varying prevalence rates across different regions and populations. The burden of CVD is influenced by factors such as age, sex, socioeconomic status, and lifestyle choices. While high-income countries have seen declines in CVD rates over the past decades, low- and middle-income countries are experiencing an increase in CVD prevalence, partly due to changing risk factors like obesity, diabetes, and hypertension. Strategies to address this burden include public health interventions to reduce risk factors, improve screening methods, and enhance access to preventive and curative services, especially in regions with limited healthcare resources.
What are the current statistics on the prevalence of diabetes worldwide?5 answersThe current statistics on the prevalence of diabetes worldwide indicate a significant increase in the number of people affected by the disease. It is estimated that there are currently 387 million people with diabetes globally, and this number is projected to rise to 592 million by the year 2035. The majority of people with diabetes, approximately 80%, live in low- and middle-income countries, with the incidence of diabetes increasing in marginalized and socioeconomically vulnerable communities. The regions with the steepest elevation in diabetes prevalence are the Eastern Mediterranean, Africa, and South East Asia, while Europe and the USA have achieved more success in curbing the epidemic. The rise in diabetes prevalence is attributed to factors such as obesity, unhealthy lifestyle, and aging. These statistics highlight the urgent need for effective interventions and public-health strategies to address the growing burden of diabetes.
What is Ischemic Heart Disease (IHD)?what risk factors included?5 answersIschemic Heart Disease (IHD) is a common cardiovascular disease characterized by a disorder of the heart muscle's blood supply due to pathological changes in the coronary vessels. The main risk factors for IHD include male gender, older age, a family history of the disease, low physical activity, arterial hypertension, diabetes mellitus, and obesity. Other factors such as tobacco use, high cholesterol levels, and triglyceride levels have also been associated with IHD. Inflammatory bowel disease (IBD) has been suggested as a possible risk factor for IHD due to the chronic inflammation process and associated endothelial dysfunction. Additionally, IHD has been found to be associated with an increased risk of dementia and cognitive decline in old age. Overall, a combination of genetic, lifestyle, and environmental factors contribute to the development of IHD.
What is the prevalence of ischemic heart disease in patients with CKD?3 answersThe prevalence of ischemic heart disease in patients with chronic kidney disease (CKD) is not explicitly mentioned in the abstracts provided. However, the abstracts do highlight that cardiovascular disease (CVD) is a common and significant problem in CKD patients, with cardiac causes accounting for a high percentage of deaths in this population. CKD patients are at increased risk of both atherosclerotic and structural heart disease, and obstructive coronary lesions have been found in asymptomatic CKD patients. Additionally, studies have shown a higher prevalence and severity of coronary artery calcification in CKD patients compared to controls. While the abstracts provide valuable information about the cardiovascular complications associated with CKD, they do not specifically address the prevalence of ischemic heart disease in this population.